Erlonat 150 Tablet
Erlonat 150 Tablet Specification
- Indication
- Non-small cell lung cancer, Pancreatic cancer
- Dosage Form
- Tablet
- Salt Composition
- Erlotinib Hydrochloride
- Feature
- Oral anti-cancer agent
- Ingredients
- Erlotinib Hydrochloride 150mg
- Application
- Oncology (anti-cancer therapy)
- Physical Color/Texture
- White to off-white tablets
- Fermentation Smell
- Odorless
- Shelf Life
- 24 months
- Product Code
- ERL-150
- Route of Administration
- Oral
- Prescription Required
- Yes
- Packaging Size
- 30 Tablets per pack
- Strength
- 150 mg
- Marketed By
- Natco Pharma Ltd.
- Therapeutic Class
- Targeted Therapy (Tyrosine Kinase Inhibitor)
Erlonat 150 Tablet Trade Information
- Minimum Order Quantity
- 100 box,
- Payment Terms
- Letter of Credit (L/C), Paypal, Western Union, Cash in Advance (CID), Cash Advance (CA)
- Delivery Time
- 30 Days
- Sample Policy
- Within a certain price range free samples are available
- Main Export Market(s)
- Australia, North America, South America, Eastern Europe, Middle East, Western Europe, Central America, Asia, Africa
- Certifications
- ISO, GMP, WHO

More Products in Oncology Drugs Category
Bortezomib Injection
Salt Composition : Bortezomib 2 mg/vial
Ingredients : Other , Bortezomib, Mannitol (as excipient)
Feature : Other, Sterile, Singleuse Vial
Fermentation Smell : Other, Odorless
Lenalidomide Tablet
Price 9-10 USD ($)
Minimum Order Quantity : 100 Boxes
Salt Composition : Lenalidomide
Ingredients : Other , Lenalidomide, Excipients
Feature : Other, Oral administration; easy to use
Fermentation Smell : Other, Odorless
Lapatinib Tablet
Price 25-50 USD ($)
Minimum Order Quantity : 50 Boxes
Salt Composition : Lapatinib
Ingredients : Other , Lapatinib, excipients (as per manufacturer)
Feature : Other, Oral administration, targeted therapy
Fermentation Smell : Other, Odorless (pharmaceutical tablet)

Send Inquiry




